|
PNN expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62458935193399E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.11022302462516E-16 |
| Normal-vs-Stage2 |
4.04590028146856E-10 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
1.53059787066923E-11 |
| Stage1-vs-Stage2 |
7.012000E-01 |
| Stage1-vs-Stage3 |
2.091800E-02 |
| Stage1-vs-Stage4 |
3.388800E-01 |
| Stage2-vs-Stage3 |
2.086000E-01 |
| Stage2-vs-Stage4 |
6.404600E-01 |
| Stage3-vs-Stage4 |
4.443200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
1.61979999968587E-07 |
| Normal-vs-Asian |
9.49809999539752E-08 |
| Caucasian-vs-AfricanAmerican |
9.928200E-01 |
| Caucasian-vs-Asian |
1.086020E-01 |
| AfricanAmerican-vs-Asian |
2.647000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.66133814775094E-16 |
| Normal-vs-Female |
1.62436730732907E-12 |
| Male-vs-Female |
9.529800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62470037423645E-12 |
| Normal-vs-Age(41-60Yrs) |
1.99840144432528E-15 |
| Normal-vs-Age(61-80Yrs) |
1.62858615482264E-12 |
| Normal-vs-Age(81-100Yrs) |
2.44159999999161E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.358400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.819400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.416000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.684600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.552200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.681400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.68890000000044E-05 |
| Classical-VS-Follicular |
2.849800E-01 |
| Classical-VS-Other |
9.771000E-01 |
| Classical-VS-Normal |
1.05879971457057E-10 |
| Tall-VS-Follicular |
7.824900E-03 |
| Tall-VS-Other |
5.002100E-02 |
| Tall-VS-Normal |
6.66133814775094E-15 |
| Follicular-VS-Other |
7.352600E-01 |
| Follicular-VS-Normal |
1.02650110633817E-11 |
| Other-VS-Normal |
5.363300E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.11022302462516E-16 |
| Normal-vs-N1 |
1.30609999482445E-08 |
| N0-vs-N1 |
4.373000E-01 |
|
|
